These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16599284)

  • 1. Effect of levetiracetam on truncal tic in neuroacanthocytosis.
    Lin FC; Wei LJ; Shih PY
    Acta Neurol Taiwan; 2006 Mar; 15(1):38-42. PubMed ID: 16599284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam in the treatment of paroxysmal kinesiogenic choreoathetosis.
    Chatterjee A; Louis ED; Frucht S
    Mov Disord; 2002 May; 17(3):614-5. PubMed ID: 12112221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroacanthocytosis and carbamazepine responsive paroxysmal dyskinesias.
    Tschopp L; Raina G; Salazar Z; Micheli F
    Parkinsonism Relat Disord; 2008; 14(5):440-2. PubMed ID: 18314374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chorea in a patient with cerebral palsy: treatment with levetiracetam.
    Recio MV; Hauser RA; Louis ED; Radhashakar H; Sullivan KL; Zesiewicz TA
    Mov Disord; 2005 Jun; 20(6):762-4. PubMed ID: 15747368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, crossover study of clonidine and levetiracetam in Tourette syndrome.
    Hedderick EF; Morris CM; Singer HS
    Pediatr Neurol; 2009 Jun; 40(6):420-5. PubMed ID: 19433274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status gelasticus associated with levetiracetam as add-on treatment.
    Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G
    Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam in the treatment of antipsychotics-resistant Tourette syndrome.
    Oulis P; Karapoulios E; Masdrakis VG; Kouzoupis AV; Karakatsanis NA; Papageorgiou C; Papadimitriou GN; Soldatos CR
    World J Biol Psychiatry; 2008; 9(1):76-7. PubMed ID: 17853302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No kinetic interaction between levetiracetam and cyclosporine: a case report.
    Franzoni E; Sarajlija J; Garone C; Malaspina E; Marchiani V
    J Child Neurol; 2007 Apr; 22(4):440-2. PubMed ID: 17621525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam-responding paroxysmal nonkinesigenic dyskinesia.
    Alemdar M; Iseri P; Selekler M; Komsuoğlu SS
    Clin Neuropharmacol; 2007; 30(4):241-4. PubMed ID: 17762321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam-induced platelet dysfunction.
    Hacquard M; Richard S; Lacour JC; Lecompte T; Vespignani H
    Epilepsy Res; 2009 Sep; 86(1):94-6. PubMed ID: 19447009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
    Zivković SA; Costa G; Bond G; Abu-Elmagd KM
    Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of Holmes tremor by levetiracetam.
    Ferlazzo E; Morgante F; Rizzo V; Sciarrone G; Meduri M; Magaudda A; Girlanda P; Quartarone A
    Mov Disord; 2008 Oct; 23(14):2101-3. PubMed ID: 18785235
    [No Abstract]   [Full Text] [Related]  

  • 15. Distressing belching and neuroacanthocytosis.
    Sibon I; Ghorayeb I; Arné P; Tison F
    Mov Disord; 2004 Jul; 19(7):856-9. PubMed ID: 15254955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam.
    Pollack MH; Jensen JE; Simon NM; Kaufman RE; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):739-43. PubMed ID: 18206286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levetiracetam for the treatment of generalized dystonia.
    Sullivan KL; Hauser RA; Louis ED; Chari G; Zesiewicz TA
    Parkinsonism Relat Disord; 2005 Nov; 11(7):469-71. PubMed ID: 16014339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam therapy for treatment of choreoathetosis in dyskinetic cerebral palsy.
    Vles GF; Hendriksen JG; Visschers A; Speth L; Nicolai J; Vles JS
    Dev Med Child Neurol; 2009 Jun; 51(6):487-90. PubMed ID: 19018837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of levetiracetam in hemifacial spasm: a case report.
    Biagio Carrieri P; Petracca M; Montella S
    Clin Neuropharmacol; 2008; 31(3):187-8. PubMed ID: 18520988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.